A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8
Biomaterials and Biosystems · 2022-12 · 8 · 100065
DOI: 10.1016/j.bbiosy.2022.100065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials and Biosystems, 2022-12. Verfasst von A Poddar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ian Potter NanoBiosensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria 3001, Austr…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ian Potter Foundation, RMIT University, Australian Nanotechnology Network.
Abstract (Originalsprache)
Metal-organic frameworks (MOFs) are an emerging group of nanomaterials for successful biomedical applications in gene therapy. The most commonly biocompatible MOFs are zinc-based ZIFs, zirconium-based UiOs, and iron-based MILs. However, despite increasing applications, a comparative study to underscore the critical factors for determining effective gene delivery by such MOFs is lacking. Herein, we evaluate the potential of UiO-66 and MIL-88B and ZIF-8 for gene therapeutics delivery; revealing the comparative importance of ZIF-8. Cytotoxicity assays proved insufficient for selecting the ideal gene delivery MOF vehicle. Synthesis conditions such as ability of the MOF scaffold to envelop the gene during in-situ synthesis, post-treatment such as washing, and gene loading efficiency proved to be the critical factors in determining the favourable MOF from the material selection perspective. Rapid in-situ synthesis under physiological conditions, successful gene loading, and low concentration requirements favour ZIF MOFs as gene delivery vehicles. Impact on cellular physiology, metabolism, and architecture revealed neutrality of the delivery system; and relative effects on pro-inflammatory and anti-inflammatory cytokines suggest immunomodulatory impact.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ian Potter NanoBiosensing Facility, NanoBiotechnology Research Laboratory (NBRL), School of Science, RMIT University, Melbourne, Victoria 3001, Australia.
- Centre for Advanced Materials and Industrial Chemistry, School of Science, RMIT University, Melbourne, Victoria 3001, Australia.
- CSIRO Manufacturing, Clayton, Victoria 3168, Australia.
Förderung
- Ian Potter Foundation
- RMIT University
- Australian Nanotechnology Network
- Australian Government
- Erasmus+
Zitieren
APA
Poddar, A., Pyreddy, S., Polash, S. A., Doherty, C. M., & Shukla, R. (2022). A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8. Biomaterials and Biosystems, 8, 100065. https://doi.org/10.1016/j.bbiosy.2022.100065
Vancouver
Poddar A, Pyreddy S, Polash SA, Doherty CM, Shukla R. A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8. Biomaterials and Biosystems. 2022;8:100065. doi:10.1016/j.bbiosy.2022.100065
BibTeX
@article{Poddar2022,
author = {Poddar, A and Pyreddy, S and Polash, S A and Doherty, C M and Shukla, R},
title = {A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8},
journal = {Biomaterials and Biosystems},
year = {2022},
volume = {8},
pages = {100065},
doi = {10.1016/j.bbiosy.2022.100065}
}
EUVIMED